menu

Investments

Aker BioMarine

Aker BioMarine is an integrated biotechnology company that develops, markets and sells krill-based ingredients for both the consumer and animal-feed markets.

AKER’S ENGAGEMENT
Aker owns 99.51 per cent of the shares in Aker BioMarine. The shareholding is valued at NOK 1.4 billion (book value). This equates to 3 per cent of Aker’s total assets at 31 December 2016.

Ola Snøve, Kjell Inge Røkke, Øyvind Eriksen and Frank O. Reite represent Aker on the company’s board of directors.

AKER’S OWNERSHIP AGENDA
Aker BioMarine is vertically integrated and controls the entire supply chain, from sustainable krill harvesting in the Antarctic to innovative product development, production, logistics and marketing. Over a 10-year period, the company has built long-term partnerships with leading branded consumer goods companies, environmental protection organisations and researchers. Superba™ Krill Oil, the company’s brand ingredient in the Omega-3 consumer market, has established itself as the global market leader. Demand for Qrill™ Aqua, a feed supplement for the aquaculture industry, continues to grow, and the product range has been expanded with feed ingredients for pets.

Profitable growth is at the top of  Aker’s agenda for its ownership of Aker BioMarine. This entails a focus on the establishment of effective value chains in the industries Aker BioMarine supplies. Aker is working to maximise Aker BioMarine’s underlying value, and continuing to assess strategic opportunities for further growth and making Aker’s investment more liquid.

For more information, please visit www.akerbiomarine.com .

Aker BioMarine

Geographic marked:
International

Sector:
Biomarine

Category:
Biotechnology

Share of Aker's total assets (4Q16)
3%

CEO & President:
Matts Johansen

Board Chairman:
Ola Snøve

Website:
www.akerbiomarine.com